Table 1

Patients’ characteristics

Characteristicsn=316
Age, median (range)60 (28–75)
BMI, median (range)28.0 (17.6–54.7)
Histology
Endometrioid274 (86.7%)
Serous22 (7%)
Mixed11 (3.4%)
Clear cell5 (1.6%)
Adenocarcinoma NOS4 (1.3%)
Grade
G158 (18.4%)
G2198 (62.6%)
G356 (17.7%)
Unknown4 (1.3%)
Myometrial invasion
<50%151 (47.8%)
>50%95 (30%)
No70 (22.2%)
FIGO stage*
IA205 (64.9%)
IB66 (20.9%)
II12 (3.8%)
IIIA3 (0.9%)
IIIB1 (0.3%)
IIIC124 (7.6%)
IIIC21 (0.3%)
IVB4 (1.3%)
LVSI
No264 (83.5%)
Yes51 (16.2%)
Unknown1 (0.3%)
Number of SLNs per pelvic side per patient. median (range)1 (0–5)
SLN mapping
Bilateral263 (83.2%)
Unilateral53 (16.8%)
Benign epithelial inclusions at ultrastaging17/668 (2.5%)
  • *FIGO stage IIIC is reported according to lymph node positivity with both methods or by either method (isolated tumor cells considered as ‘negative’)

  • BMI, body mass index; FIGO, International Federation of Gynecology and Obstetrics; LVSI, lymphovascular space invasion; NOS, not otherwise specified; SLN, sentinel lymph node.